Navy and Marine Corps active duty mortality patterns for 1995 to 1999.

The authors analyze all Navy and Marine Corps active duty deaths from January 1, 1995 through December 31, 1999 (Navy, N=1231; Marine Corps, N=701). Data were obtained from official Navy and Marine Corps sources, including the Report of Casualty (DD form 1300) and the Navy Personnel Casualty Report (Control Symbol NMPC 1770-4) or the Marine Corps Personnel Casualty Report (MC-3040-02), as appropriate. Overall fatality rates were 68.2 per 100,000 active duty Navy personnel and 84.2 for active duty Marine Corps personnel. Rates were generally lower than those noted in previous studies and lower than comparable civilian groups. The officer fatality rates were strongly affected by aircraft mishap-related deaths. The only subgroup displaying higher rates than their civilian counterparts was mishap-related deaths for enlisted Marines age 17 to 24 years old.

Not a usual suspect; rabeprazole therapy presenting as a severe neuropsychiatric illness: case report.

We report the case of a patient who, as a result of exposure to the proton pump inhibitor rabeprazole, developed a severe and disabling admixture of neuropsychiatric symptoms. Because of its widely appreciated placebo-like side effect profile, rabeprazole was never suspected as being the cause of his symptoms. Instead, a somatoform spectrum disorder was assigned based on the patient's atypical symptom presentation, progressive course, subjective psychological distress, intemperate consumption of healthcare resources over a relatively brief period of time and lack of any medical explanation for his symptoms at that time, despite exhaustive laboratory and radiologic work-ups. This case report reinforces the notion that even a medication such as rabeprazole, with an established safety and tolerability profile, may be associated with side effects severe enough to mimic disabling neuropsychiatric illness.